Peter Belt, PhD, Chief Executive Officer (foto)
Bart de Boer, MSc, Chief Technology Officer (foto)
Bart de Boer obtained his masters in Electrical Engineering at the Eindhoven University of Technology. He started his career as a Scientist at Philips Research where was involved in, among others, magneto-resistive biosensors. After 10 years at Philips, he joined the Netherlands Organisation for Applied Scientific Research – TNO, where he was active as System Architect and Project Manager in the area of integrated optical biosensors. In 2018 he founded Delta Diagnostics to commercialize the biosensing technology he developed at TNO, together with Peter Harmsma. Bart has more than 15 years’ experience in the field of biosensing and biomedical sensor systems and hold over 40 patents.
Peter Harmsma, PhD, Manager Product Development (foto)
Peter Harmsma has been lead Sr. Scientist on integrated optics at the Netherlands Organisation for Applied Scientific Research – TNO for over 10 years. He holds a PhD in integrated optics, and was co-founder of the start-up company ThreeFive Photonics (Delft, 2000). This company commercialized the integrated optics technology developed at the Delft University of Technology for telecom applications. Peter is specialized in the design of integrated photonics chips, and in test and measurement strategies. He has an extensive network in the European (integrated) optics community, and has played an important role in several integrated photonics-related European projects. Together with Bart, Peter developed the technology that Delta Diagnostics commercializes within the Optic department of TNO.
Corné van den Kieboom, PhD, Lead Assay Developer
Corné van den Kieboom has over 10 years of experience in assay development for molecular diagnostics. He obtained his PhD on novel diagnostic techniques and biomarker discovery at the Radboud University Medical Centre. After his PhD, he worked at Innosieve Diagnostics as lead assay developer and was responsible for test kit production scale-up. Currently, Corné focusses on bridging the gap between clinic and diagnostics developers. Early 2018, he founded The contract R&D and consultancy company “Inventin”. Over the years, Corné collaborated with many innovative players in the field of platform development, e.g. NXP Semiconductors, IMEC, Biocartis and BiosparQ.